Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap

Annals of the Rheumatic Diseases

Volumn 76, Issue 6, 2017, Pages 1057-1063

  Lacaille, Diane ^a,b   Avina Zubieta, J Antonio ^a,b   Sayre, Eric C ^a   Abrahamowicz, Michal ^c  

^a ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Epidemiology; Outcomes research; Rheumatoid Arthritis

Indexed keywords

ADULT; ALL CAUSE MORTALITY; ARTICLE; BRITISH COLUMBIA; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RATE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; TREND STUDY; AGED; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CAUSE OF DEATH; COMORBIDITY; CROSS INFECTION; FOLLOW UP; HOSPITALIZATION; LONGITUDINAL STUDY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BRITISH COLUMBIA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CAUSE OF DEATH; COMORBIDITY; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85009809543     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2016-209562     Document Type: Article

References (76)

1. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953;249:553-6.
2. Naz SM, Symmons DPM. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871-83.
3. Gabriel SE. Why do persons with rheumatoid arthritis still die prematurely? Ann Rheum Dis 2008;67(Suppl 3):iii30-4.
4. Dadoun S, Zeboulon-Ktorza N, Combescure C, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-Analysis. Joint Bone Spine 2013;80:29-33.
5. Myasoedova E, Davis Iii JM, Crowson CS, et al. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010;12: 379-85.
6. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26:S35-61.
7. Carmona L, Cross M, Williams B, et al. Rheumatoid arthritis. Best Pract Res Clin Rheumatol 2010;24:733-45.
8. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-Analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
9. Sihvonen S, Korpela M, Laippala P, et al. Death rates and causes of death in patients with rheumatoid arthritis: A population-based study. Scand J Rheumatol 2004;33:221-7.
10. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: A 25-year prospective follow-up. J Rheumatol 1984;11:158-61.
11. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445-51.
12. Mitchell DM, Spitz PW, Young DY, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706.
13. Mutru O, Laakso M, Isomäki H, et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985;290:1797-9.
14. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, et al. Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149.
15. Prior P, Symmons DP, Scott DL, et al. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
16. Ward MM. Recent improvements in survival in patients with RA: better outcomes or different study designs? Arthritis Rheum 2001;44:1467-9.
17. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 1999;58:11-14.
18. Kroot EJ, Van Leeuwen MA, Van Rijswijk MH, et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-8.
19. Peltomaa R, Paimela L, Kautiainen H, et al. Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis. Ann Rheum Dis 2002;61:889-94.
20. Goodson NJ, Wiles NJ, Lunt M, et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002;46:2010-19.
21. Goodson N, Marks J, Lunt M, et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005;64:1595-601.
22. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatol 2007;46:350-7.
23. Radovits BJ, Fransen J, Al Shamma S, et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:362-70.
24. Wallberg-Jonsson S, Johansson H, Ohman ML, et al. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
25. Corbett M, Dalton S, Young A, et al. Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years. Rheumatol 1993;32:717-23.
26. Erhardt CC, Mumford PA, Venables PJ, et al. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study. Ann Rheum Dis 1989;48:7-13.
27. Pincus T, Brooks RH, Callahan LF. Prediction of long-Term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med 1994;120:26-34.
28. Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, et al. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219-23.
29. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007;57:125-32.
30. Navarro-Cano G, Del Rincón I, Pogosian S, et al. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheum 2003;48:2425-33.
31. Wolfe F, Michaud K, Gefeller O, et al. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1530-42.
32. Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74.
33. Strand V, Singh JA. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care 2007;13(Suppl 9):S237-51.
34. Curtis JR, Singh JA. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther 2011;33:679-707.
35. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
36. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
37. Bykerk VP, Akhavan P, Hazlewood GS, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.
38. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
39. Gonzalez A, Maradit Kremers H, Crowson CS, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007;56:3583-7.
40. Bergström U, Jacobsson LTH, Turesson C, et al. Internal Medicine Research U, Institutionen för kliniska vetenskaper M, Sektionen för AMK. Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmö, Sweden. Rheumatol (Oxford, England) 2009;48:1600-5.
41. Humphreys JH, Warner A, Chipping J, et al. Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the Norfolk arthritis register. Arthritis Care Res (Hoboken) 2014;66:1296-301.
42. Björnadal L, Baecklund E, Yin L, et al. Decreasing mortality in patients with rheumatoid arthritis: results from large population based cohort in Sweden 1964-95. J Rheumatol 2002;29:906-12.
43. Ziade N, Jougla E, Coste J. Population-level influence of rheumatoid arthritis on mortality and recent trends: A multiple cause-of-death analysis in France, 1970-2002. J Rheumatol 2008;35:1950-7.
44. Pincus T, ODell J KJ. Combination therapy with multiple DMARDs in RA: A preventive strategy. Ann Intern Med. 1999;131:768-74.
45. Fries JF. Current treatment paradigms in RA. Rheumatol(Oxford) 2000;391):30-5.
46. Wollheim FA. Approaches to RA in 2000. Curr Opin Rheumatol 2001;13:193-201.
47. American College of Rheumatology Ad Hoc Committee on clinical guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-46.
48. Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862-73.
49. del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
50. Goodson NJ, Wiles NJ, Lunt M, et al. Mortality in early inflammatory polyarthritis. Cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002;46:2010-19.
51. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: A disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35:8-17.
52. Sattar N, McCarey DW, Capell H, et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
53. van Leuven SI, Franssen R, Kastelein JJ, et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatol (Oxford) 2008;47:3-7.
54. Lacaille D, Anis AH, Guh DP, et al. Gaps in care for rheumatoid arthritis: A population study. Arthritis Rheum 2005;53:241-8.
55. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-92.
56. Chang J, Rogers P, Lacaille D. Can American College of Rheumatology criteria for rheumatoid arthritis be assessed using self-report data? Comparison of self-reported data with chart review. Arthritis Rheum 2011;63(Suppl):S49.
57. British Columbia Ministry of Health [creator] (2012): Medical Services Plan (MSP) Payment Information File. Population Data BC [ publisher]. Data Extract. MOH, 2012. http://www.popdata.bc.ca/data
58. CIHI [creator] (2011): Discharge Abstract Database (Hospital Separations). Population Data BC [publisher]. Data Extract. MOH, 2012. http://www.popdata.bc.ca/data
59. BC Vital Statistics Agency [creator] (2011): Vital Statistics Deaths. Population Data BC [ publisher]. Data Extract. BC Vital Statistics Agency (2012). http://www.popdata. bc.ca/data
60. Solomon DH, Massarotti E, Garg R, et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA 2011;305:2525-31.
61. Etminan M, Forooghian F, Brophy JM, et al. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012;307:1414-19.
62. Lacaille D, Guh D, Abrahamowicz M, et al. Use of non-biologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum 2008;59:1074-81.
63. De Vera MA, Choi H, Abrahamowicz M, et al. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: A population-based cohort study. Ann Rheum Dis 2011;70:1020-4.
64. De Vera MA, Choi H, Abrahamowicz M, et al. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: A population-based study. Arthritis Care Res (Hoboken) 2012;64:809-16.
65. Avina-Zubieta JA, Abrahamowicz M, Choi HK, et al. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: A population-based study. Ann Rheum Dis 2011;70:990-5.
66. Avina-Zubieta JA, Abrahamowicz M, De Vera MA, et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: A population-based study. Rheumatol (Oxford) 2013;52:68-75.
67. Yurkovich M, Avina-Zubieta JA, Thomas J, et al. A systematic review identified valid comorbidity indices derived from administrative data. J Clin Epidemiol 2015;68:3-14.
68. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 1993;46:1075-90.
69. Romano PS, Roos LL, Jollis JG. Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1085-90.
70. Uhlig T, Kvien TK. Is rheumatoid arthritis disappearing? Ann Rheum Dis 2005;64:7-10.
71. Widdifield J, Paterson JM, Bernatsky S, et al. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheum 2014;66:786-93.
72. Liu A, Abrahamowicz M, Siemiatycki J. Conditions for confounding of interactions. Pharmacoepidemiol Drug Saf 2016;25:287-96.
73. Leffondré K, Abrahamowicz M, Siemiatycki J, et al. Modeling smoking history: A comparison of different approaches. Am J Epidemiol 2002;156:813-23.
74. Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.
75. Myasoedova E, Crowson CS, Matteson EL, et al. Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA? [abstract]. Arthritis Rheumatol 2015;67(Suppl 10). http://acrabstracts.org/abstract/decreased-cardiovascular-mortality-in-patientswith-incident-rheumatoid-Arthritis-ra-in-recent-years-dawn-of-A-new-era-incardiovascular-disease-in-ra/(accessed 2 Feb 2016).
76. Lu N, Choi HK, Schoenfeld SR, et al. Improved survival in rheumatoid arthritis: A general population-based study [abstract]. Arthritis Rheumatol 2015;67(Suppl 10). http://acrabstracts.org/abstract/improved-survival-in-rheumatoid-Arthritis-A-generalpopulation-based-study/(accessed 2 Feb 2016).